A metabolic discrimination model for nasopharyngeal carcinoma and its potential role in the therapeutic evaluation of radiotherapy

Metabolomics

Volumn 10, Issue 4, 2014, Pages 697-708

  Yi, Lunzhao ^a   Song, Chenchao ^a   Hu, Zheyu ^a   Yang, Lifang ^a   Xiao, Lanbo ^a   Yi, Bin ^b   Jiang, Wuzhong ^b   Cao, Ya ^a   Sun, Lunquan ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Metabolic profiling; Nasopharyngeal carcinoma; Radiotherapy; Therapeutic evaluation

Indexed keywords

ALANINE; AMINO ACID; ARACHIDONIC ACID; BIOLOGICAL MARKER; CHOLESTEROL; FRUCTOSE; GLUCOSE; GLYCEROL 1 HEXADECANOATE; GLYCEROL DERIVATIVE; GLYCINE; HYDROXYBUTYRIC ACID; INOSITOL; ISOLEUCINE; LACTIC ACID; LINOLEIC ACID; NORVALINE; OLEIC ACID; PALMITIC ACID; PHENYLALANINE; PROLINE; PYROGLUTAMIC ACID; SERINE; STEARIC ACID; THREONINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER PROGNOSIS; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; FLOW RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; METABOLIC DISORDER; METABOLOMICS; NASOPHARYNX CARCINOMA; RADIATION DOSE; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

EID: 84904399758     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-013-0606-x     Document Type: Article

References (38)

1. Arcidiacono, B., Iiritano, S., Nocera, A., Possidente, K., Nevolo, M. T., Ventura, V., et al. (2012). Insulin resistance and cancer risk: An overview of the pathogenetic mechanisms. Experimental Diabetes Research, 2012, 789174. doi: 10. 1155/2012/789174.
2. Asiago, V. M., Alvarado, L. Z., Shanaiah, N., Gowda, G. A., Owusu-Sarfo, K., Ballas, R. A., et al. (2010). Early detection of recurrent breast cancer using metabolite profiling. Cancer Research, 70(21), 8309-8318. doi: 10. 1158/0008-5472. CAN-10-1319.
3. Azevedo-Martins, A. K., & Curi, R. (2008). Fatty acids decrease catalase activity in human leukaemia cell lines. Cell Biochemistry and Function, 26(1), 87-94. doi: 10. 1002/cbf. 1404.
4. Bonuccelli, G., Tsirigos, A., Whitaker-Menezes, D., Pavlides, S., Pestell, R. G., Chiavarina, B., et al. (2010). Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle, 9(17), 3506-3514.
5. Cai, X., Dong, J., Zou, L., Xue, X., Zhang, X., & Liang, X. (2011). Metabonomic study of lung cancer and the effects of radiotherapy on lung cancer patients: Analysis of highly polar metabolites by ultraperformance HILIC coupled with Q-TOF MS. Chromatographia, 74(5-6), 391-398. doi: 10. 1007/s10337-011-2077-4.
6. Chang, E. T., & Adami, H. O. (2006). The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiology, Biomarkers & Prevention, 15(10), 1765-1777. doi: 10. 1158/1055-9965. EPI-06-0353.
7. Chen, L., Hu, C. S., Chen, X. Z., Hu, G. Q., Cheng, Z. B., Sun, Y., et al. (2012). Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. Lancet Oncology, 13(2), 163-171. doi: 10. 1016/S1470-2045(11)70320-5.
8. Chen, Y. K., Su, C. T., Ding, H. J., Chi, K. H., Liang, J. A., Shen, Y. Y., et al. (2006). Clinical usefulness of fused PET/CT compared with PET alone or CT alone in nasopharyngeal carcinoma patients. Anticancer Research, 26(2B), 1471-1477.
9. Chen, Y., Zhang, R., Song, Y., He, J., Sun, J., Bai, J., et al. (2009). RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: Finding potential biomarkers for breast cancer. Analyst, 134(10), 2003-2011. doi: 10. 1039/b907243h.
10. Cowey, S., & Hardy, R. W. (2006). The metabolic syndrome: A high-risk state for cancer? American Journal of Pathology, 169(5), 1505-1522. doi: 10. 2353/ajpath. 2006. 051090.
11. Daker, M., Bhuvanendran, S., Ahmad, M., Takada, K., & Khoo, A. S. (2013). Deregulation of lipid metabolism pathway genes in nasopharyngeal carcinoma cells. Molecular Medicine Reports, 7(3), 731-741. 2012. 1253.
12. Daniel, C. R., McCullough, M. L., Patel, R. C., Jacobs, E. J., Flanders, W. D., Thun, M. J., et al. (2009). Dietary intake of omega-6 and omega-3 fatty acids and risk of colorectal cancer in a prospective cohort of U. S. men and women. Cancer Epidemiology, Biomarkers & Prevention, 18(2), 516-525. doi: 10. 1158/1055-9965. EPI-08-0750.
13. Das, U. N. (1991). Tumoricidal action of cis-unsaturated fatty acids and their relationship to free radicals and lipid peroxidation. Cancer Letters, 56(3), 235-243. doi: 10. 1016/0304-3835(91)90008-6.
14. de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., et al. (2012). Global burden of cancers attributable to infections in 2008: A review and synthetic analysis. Lancet Oncology, 13(6), 607-615. doi: 10. 1016/S1470-2045(12)70137-7.
15. Dupertuis, Y. M., Meguid, M. M., & Pichard, C. (2007). Colon cancer therapy: New perspectives of nutritional manipulations using polyunsaturated fatty acids. Current Opinion in Clinical Nutrition & Metabolic Care, 10(4), 427-432. doi: 10. 1097/MCO. 0b013e3281e2c9d4.
16. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., & DuBois, R. N. (1994). Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107(4), 1183-1188.
17. Frickenschmidt, A., Frohlich, H., Bullinger, D., Zell, A., Laufer, S., Gleiter, C. H., et al. (2008). Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients. Biomarkers, 13(4), 435-449. doi: 10. 1080/13547500802012858.
18. Hua, Y. J., Han, F., Lu, L. X., Mai, H. Q., Guo, X., Hong, M. H., et al. (2012). Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy. European Journal of Cancer, 48(18), 3422-3428. doi: 10. 1016/j. ejca. 2012. 06. 016.
19. Icard, P., & Lincet, H. (2013). The cancer tumor: A metabolic parasite? Bulletin du Cancer,. doi: 10. 1684/bdc. 2013. 1742.
20. Kim, K., Aronov, P., Zakharkin, S. O., Anderson, D., Perroud, B., Thompson, I. M., et al. (2009). Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Molecular and Cellular Proteomics, 8(3), 558-570. doi: 10. 1074/mcp. M800165-MCP200.
21. Kitagawa, N., Kondo, S., Wakisaka, N., Zen, Y., Nakanishi, Y., Tsuji, A., et al. (2013). Expression of seven-in-absentia homologue 1 and hypoxia-inducible factor 1 alpha: Novel prognostic factors of nasopharyngeal carcinoma. Cancer Letters, 331(1), 52-57. doi: 10. 1016/j. canlet. 2012. 12. 002.
22. Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011). Otto Warburg's contributions to current concepts of cancer metabolism. Nature Reviews Cancer, 11(5), 325-337. doi: 10. 1038/nrc3038.
23. Lam, W. W., Yuen, H. Y., Wong, K. S., Leung, S. F., Liu, K. H., & Metreweli, C. (2001). Clinically underdetected asymptomatic and symptomatic carotid stenosis as a late complication of radiotherapy in Chinese nasopharyngeal carcinoma patients. Head and Neck, 23(9), 780-784. doi: 10. 1002/hed. 1111.
24. Lv, W., & Yang, T. (2012). Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC-MS and multivariate statistical analysis. Clinical Biochemistry, 45(1-2), 127-133. doi: 10. 1016/j. clinbiochem. 2011. 10. 011.
25. Mackie, A. M., Epstein, J. B., Wu, J. S. Y., & Stevenson-Moore, P. (2000). Nasopharyngeal carcinoma: The role of the dentist in assessment, early diagnosis and care before and after cancer therapy. Oral Oncology, 36(5), 397-403. doi: 10. 1016/s1368-8375(00)00034-8.
26. Martinez-Outschoorn, U. E., Lin, Z., Whitaker-Menezes, D., Howell, A., Sotgia, F., & Lisanti, M. P. (2012). Ketone body utilization drives tumor growth and metastasis. Cell Cycle, 11(21), 3964-3971. doi: 10. 4161/cc. 22137.
27. Natarajan, S. K., Zhu, W., Liang, X., Zhang, L., Demers, A. J., Zimmerman, M. C., et al. (2012). Proline dehydrogenase is essential for proline protection against hydrogen peroxide-induced cell death. Free Radical Biology and Medicine, 53(5), 1181-1191. doi: 10. 1016/j. freeradbiomed. 2012. 07. 002.
28. Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., et al. (2009). Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature, 457(7231), 910-914. doi: 10. 1038/nature07762.
29. Tabatabaei, P., Bergstrom, P., Henriksson, R., & Bergenheim, A. T. (2008). Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy. Journal of Neuro-oncology, 90(1), 35-39. doi: 10. 1007/s11060-008-9625-2.
30. Tang, F., Xie, C., Huang, D., Wu, Y., Zeng, M., Yi, L., et al. (2011). Novel potential markers of nasopharyngeal carcinoma for diagnosis and therapy. Clinical Biochemistry, 44(8-9), 711-718. doi: 10. 1016/j. clinbiochem. 2011. 03. 025.
31. Tapp, H. S., Defernez, M., & Kemsley, E. K. (2003). FTIR spectroscopy and multivariate analysis can distinguish the geographic origin of extra virgin olive oils. Journal of Agriculture and Food Chemistry, 51(21), 6110-6115. doi: 10. 1021/jf030232s.
32. Thiebaut, A. C., Chajes, V., Gerber, M., Boutron-Ruault, M. C., Joulin, V., Lenoir, G., et al. (2009). Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer. International Journal of Cancer, 124(4), 924-931. doi: 10. 1002/ijc. 23980.
33. 1H NMR-based metabolomics. Neoplasia, 11(3), 269-276. (264p following 269).
34. Xu, J., Chen, Y., Zhang, R., Song, Y., Cao, J., Bi, N., et al. (2013). Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers. Molecular and Cellular Proteomics,. doi: 10. 1074/mcp. M112. 022830.
35. Yi, L.-Z., He, J., Liang, Y.-Z., Yuan, D.-L., & Chau, F.-T. (2006). Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GUMS and PLS-LDA. FEBS Letters, 580(30), 6837-6845. doi: 10. 1016/j. febslet. 2006. 11. 043.
36. Zeng, L., Wu, G. Z., Goh, K. J., Lee, Y. M., Ng, C. C., You, A. B., et al. (2008). Saturated fatty acids modulate cell response to DNA damage: Implication for their role in tumorigenesis. PLoS ONE, 3(6), e2329. doi: 10. 1371/journal. pone. 0002329.
37. Zhang, J. X., Qian, D., Wang, F. W., Liao, D. Z., Wei, J. H., Tong, Z. T., et al. (2013). MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy. Cancer Letters, 329(1), 91-98. doi: 10. 1016/j. canlet. 2012. 10. 033.
38. Zheng, F. J., Ye, H. B., Wu, M. S., Lian, Y. F., Qian, C. N., & Zeng, Y. X. (2012). Repressing malic enzyme 1 redirects glucose metabolism, unbalances the redox state, and attenuates migratory and invasive abilities in nasopharyngeal carcinoma cell lines. Chinese Journal of Cancer, 31(11), 519-531. doi: 10. 5732/cjc. 012. 10088.